| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:45:16
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:45:14
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:45:12
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:45:10
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:44:56
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:44:46
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:44:44
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:44:41
|
|
|
Private Notes
|
|
| 《 UegjXTeJrAーYrgflcpXrrlR―2019/6/7 16:44:36
|
|
Co-operation:
How would you like the money?  http://tubegalore.in.net/ www.tubegalore
  The drugmaker said results of a mid-stage study of its drugto treat the breakdown of brain nerve cells will be delayeduntil early 2014. The drug, PBT2, is also being tested in threeother clinical trials including Alzheimer's.
|
|
| 《 FlPfOjjNvqーtMYJCqMBSBi―2019/6/7 15:39:22
|
|
|
Private Notes
|
|